NOV 21, 2017 4:13 PM PST

The Blood-Brain Barrier: A Barrier To Drug Uptake

WRITTEN BY: Courtney Schaal

The brain is one of our most vital organs pertinent to life and all of our bodily functions.  So it is not surprising that we come equipped with a blood-brain barrier to ensure that not everything that enters the bloodstream or the body is able to make it to the brain.  It acts as both a filter and protectant.  The brain possesses epithelial-like tight junctions within its capillary endothelium which is thought to contribute to its ability to provide such a barrier.  It has long been known that the blood-brain barrier prevents the uptake of a large majority of therapeutic agents into the brain, posing a challenge for researchers seeking to treat diseases of the brain such as cancers and other diseases.  There are certain chemical properties that make a compound more likely to cross the blood-brain barrier which are not present in most drugs; however, there are groups of chemists who specialize in optimizing and re-engineering drugs for this exact purpose: to cross the blood brain barrier and successfully carry out their intended function.  This video highlights the physiology of the bood-brain barrier.

Sources: Wikipedia, Journal of Cebral Blood Flow and Metabolism, Johns Hopkins University, Youtube

About the Author
You May Also Like
DEC 18, 2019
Drug Discovery & Development
DEC 18, 2019
A tool that simplifies the hunt for cancer drugs
Cells have long been the internal hubs for proteins that hold a wide variety of unique functions. Disorders on how a cell synthesizes a protein can affect ...
DEC 21, 2019
Drug Discovery & Development
DEC 21, 2019
Magic Mushrooms Pass First Clinical Trial Against Depression
With the efficacy of selective serotonin reuptake inhibitors such as Prozac increasingly coming under question, the search for new pharmaceutical treatment...
DEC 25, 2019
Drug Discovery & Development
DEC 25, 2019
New Drug to Make Breast Cancer Treatment More Affordable
The US Food and Drug Administration has granted accelerated approval to new breast cancer drug, trastuzumab deruxtecan. The drug’s increasing recogni...
DEC 23, 2019
Drug Discovery & Development
DEC 23, 2019
FDA Approves New Schizophrenic Drug
The US Food and Drug Administration (FDA) has approved an atypical antipsychotic Caplyta (lumateperone; Intra-Cellular Therapies) for the treating schizoph...
FEB 04, 2020
Cancer
FEB 04, 2020
The role of SRR in colorectal cancer
Researchers from Osaka University have recently discovered a new function of the multifunctional enzyme entitled serine racemase (SRR). According to the te...
FEB 21, 2020
Health & Medicine
FEB 21, 2020
Should You Really be Scared of the Coronavirus?
As of February 21st, the death toll for coronavirus reached 2,250, 55,707 currently infected, of which 12,066 (22%) are in a serious or critical condition....
Loading Comments...